Insider · CIK 0002071094
John Robert Krutz
Files at CLMT (Calumet, Inc. /DE). First filing -, latest -.
John Robert Krutz files SEC Form 4 as officer at CLMT (Calumet, Inc. /DE). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Robert Krutz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | CLMT Calumet, Inc. /DE | AGrant or award Restricted Stock Unitderivative | +931 | $0.00 | $0 | 931 | Apr 2, 2026 |
| Mar 31, 2026 | CLMT Calumet, Inc. /DE | AGrant or award Restricted Stock Unitsderivative | +310 | $0.00 | $0 | 310 | Apr 2, 2026 |
| Feb 24, 2026 | CLMT Calumet, Inc. /DE | AGrant or award Restricted Stock Unitderivative | +2,365 | $0.00 | $0 | 2,365 | Feb 26, 2026 |
| May 28, 2025 | CLMT Calumet, Inc. /DE | AGrant or award Restricted Stock Unitderivative | +5,660 | $0.00 | $0 | 5,660 | May 30, 2025 |
Questions about John Robert Krutz
Answered from the filings on this page, as of the latest one.
Is John Robert Krutz buying or selling?
John Robert Krutz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Robert Krutz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Robert Krutz has 0.
Where does John Robert Krutz file Form 4?
John Robert Krutz has filed Form 4 at CLMT (Calumet, Inc. /DE) as Chief Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.